Article
Discovery of novel agonists and antagonists of the free fatty acid receptor 1 (FFAR1) using virtual screening.
Journal of medicinal chemistry - 14 Feb 2008
Tikhonova Irina G, Sum Chi Shing, Neumann Susanne, Engel Stanislav, Raaka Bruce M, Costanzi Stefano, Gershengorn Marvin C
Abstract excerpt
The G-protein-coupled receptor free fatty acid receptor 1 (FFAR1), previously named GPR40, is a possible novel target for the treatment of type 2 diabetes. In an attempt to identify new ligands for this receptor, we performed virtual screening (VS) based on two-dimensional (2D) similarity, three-dimensional (3D) pharmacophore searches, and docking studies by using the structure of known agonists and our model of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
